CRNA Interview Vasopressors: Receptors and Cellular Mechanisms
Vasopressin does not stimulate adrenergic beta receptors, but heart rate and cardiac output can decrease.Source
Septic shock can involve inappropriately low endogenous vasopressin relative to the degree of hypotension. Added vasopressin is a nonadrenergic vasopressor, rather than proof the patient exhausted all hormone stores.Source
Beta-1 signaling raises cyclic AMP and activates protein kinase A (PKA), rather than protein kinase C (PKC).Source
Epinephrine can raise lactate through beta-2-mediated aerobic glycolysis. A rising lactate still needs assessment of perfusion and other causes. It is not guaranteed to normalize within 24 hours.Source
How do you explain vasopressor mechanisms in a CRNA interview?
To explain a vasoactive drug, connect the patient’s problem with the receptor, intracellular signal and hemodynamic effect. This older lesson compares adrenergic pathways, vasopressin and inodilators. Read the corrections above the player before watching: several recorded statements require qualification, including vasopressin’s cardiac effects, hormone deficiency and epinephrine-related lactate.
Key takeaways
- Alpha-1 and V1a receptors increase vascular tone through Gq-related signaling.
- Beta-1 signaling raises cyclic AMP and activates protein kinase A.
- Interpret an epinephrine-associated lactate rise alongside perfusion and other causes.
In this video
- - What Do CRNA Interviewers Actually Ask About Vasopressors?
- - Who Is This Video For?
- - What Is the MAP = CO × SVR Framework?
- - What Does Alpha-1 Actually Do Inside the Cell?
- - How Does Each Vasopressor Plug Into That Framework?
- - What Makes Phenylephrine and Vasopressin Different?
- - How Do Dobutamine and Milrinone Both Raise Cardiac Output Through Different Pathways?
- - The Framework: One Slide, Every Vasopressor
- - Free Resources + Where to Go Next
How do you explain the receptor-to-patient pathway?
Start with the hemodynamic goal. Alpha-1 activation on vascular smooth muscle increases contraction through Gq, phospholipase C, IP3 and calcium-dependent signaling. Beta-1 activation uses Gs, cyclic AMP and protein kinase A to support cardiac activity.
The tissue matters. An intracellular signal does not produce the same response in every cell. Practice one pathway completely, then connect its expected effect to pressure, flow and the adverse effects you would assess.
How do vasopressin and inodilators differ from adrenergic vasopressors?
Vasopressin activates V1a receptors rather than adrenergic receptors. It raises vascular resistance, and heart rate or cardiac output also changes. Lack of beta-receptor stimulation does not mean the drug has no cardiac consequence.
Dobutamine acts mainly through beta-1 signaling. Milrinone inhibits phosphodiesterase 3, reducing cyclic AMP breakdown. Both support contraction and have vasodilatory effects. Their mechanisms differ, so the name “inodilator” does not supply the full explanation.
What needs qualification in the older recording?
Septic shock involves variable endogenous vasopressin responses. A relative deficiency does not establish complete exhaustion of hormone stores in every patient. Added vasopressin remains a vasoactive treatment with its own benefits and risks.
Epinephrine also increases lactate through beta-2-mediated metabolic effects. This does not exclude hypoperfusion or other causes in the same patient, and a fixed 24-hour normalization is not guaranteed. Use current sepsis guidance and reassessment rather than dismissing the trend.
